HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Po-Hui Wang Selected Research

Infections

6/2013Mortality in Emergency Department Sepsis score as a prognostic indicator in patients with pyogenic liver abscess.
10/2010Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study.
5/2009Pyogenic liver abscess in the elderly: clinical features, outcomes and prognostic factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Po-Hui Wang Research Topics

Disease

49Neoplasms (Cancer)
05/2022 - 01/2003
38Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 05/2002
15Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
01/2015 - 01/2008
12Carcinogenesis
05/2021 - 01/2003
7Abscess
11/2013 - 08/2007
7Adenocarcinoma
05/2010 - 05/2009
6Carcinoma (Carcinomatosis)
03/2022 - 05/2002
6Neoplasm Metastasis (Metastasis)
01/2022 - 11/2011
5Lymphatic Metastasis
01/2022 - 03/2008
4Endometrial Neoplasms (Endometrial Cancer)
10/2021 - 11/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 10/2007
3Endometriosis
03/2022 - 01/2020
3Diabetes Mellitus
01/2019 - 08/2007
3Hypertension (High Blood Pressure)
01/2019 - 01/2015
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 01/2015
3Infections
06/2013 - 05/2009
2Nasopharyngeal Carcinoma
05/2022 - 10/2020
2Uterine Neoplasms (Uterine Cancer)
12/2021 - 10/2019
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 01/2016
2Atherosclerosis
01/2019 - 01/2015
2Uterine Cervical Dysplasia
01/2019 - 10/2007
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 08/2011
2Inflammation (Inflammations)
01/2015 - 10/2011
2Pleural Effusion (Pleural Effusions)
05/2009 - 08/2007
1Adenocarcinoma of Lung
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
12/2021
1Hyperinsulinism (Hyperinsulinemia)
05/2021
1Drug-Related Side Effects and Adverse Reactions
05/2021
1Hyperglycemia
05/2021
1Type 2 Diabetes Mellitus (MODY)
05/2021
1Insulin Resistance
05/2021
1Hypoxia (Hypoxemia)
03/2021
1Rhinosinusitis
01/2020
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2019

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
03/2021 - 06/2006
7Biological ProductsIBA
05/2022 - 08/2008
7Messenger RNA (mRNA)IBA
12/2020 - 10/2007
7Monoclonal AntibodiesIBA
12/2012 - 08/2008
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2011 - 10/2007
5Lipocalin-2IBA
06/2014 - 05/2011
4Small Interfering RNA (siRNA)IBA
02/2022 - 11/2011
4Pharmaceutical PreparationsIBA
01/2022 - 08/2007
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2020 - 10/2007
4Plasminogen Activators (Plasminogen Activator)IBA
01/2016 - 12/2011
4Biomarkers (Surrogate Marker)IBA
06/2014 - 06/2010
4ParaffinIBA
05/2010 - 12/2008
3Long Noncoding RNAIBA
01/2022 - 01/2019
3Plasminogen Activator Inhibitor 1IBA
01/2016 - 12/2011
3Indicators and Reagents (Reagents)IBA
06/2013 - 01/2003
3Urokinase Plasminogen Activator ReceptorsIBA
01/2013 - 12/2011
3Keratin-8 (Keratin 8)IBA
12/2012 - 05/2010
3Anti-Bacterial Agents (Antibiotics)IBA
02/2012 - 08/2007
3Tissue Inhibitor of Metalloproteinase-2IBA
08/2011 - 11/2009
3Formaldehyde (Formol)FDA Link
05/2010 - 06/2009
3Telomerase (Telomerase Reverse Transcriptase)IBA
12/2008 - 05/2007
2PlatinumIBA
03/2022 - 01/2011
2Hypoglycemic Agents (Hypoglycemics)IBA
05/2021 - 01/2019
2Carbonic Anhydrase IXIBA
03/2021 - 01/2018
2PTX3 proteinIBA
01/2021 - 10/2011
2EnzymesIBA
01/2020 - 06/2009
2ABT-737IBA
12/2019 - 10/2019
2A-factor (Streptomyces)IBA
10/2016 - 10/2012
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2016 - 01/2015
2Chemokine ReceptorsIBA
01/2015 - 10/2013
2OsteopontinIBA
06/2014 - 11/2010
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2013 - 06/2010
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2013 - 08/2012
2CAM 5.2 antigenIBA
12/2012 - 08/2011
2Metalloproteases (Metalloproteinases)IBA
09/2012 - 11/2009
2Matrix Metalloproteinases (MMPs)IBA
11/2009 - 10/2007
2Cyclin-Dependent Kinase Inhibitor p16IBA
09/2009 - 06/2009
2CytokinesIBA
01/2008 - 01/2008
2Phosphotransferases (Kinase)IBA
06/2006 - 01/2003
1dihydromyricetinIBA
05/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2022
1Glucose (Dextrose)FDA LinkGeneric
05/2022
1S100 Calcium-Binding Protein A4IBA
02/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2022
1arctiinIBA
02/2022
1GestrinoneIBA
01/2022
1Tissue Inhibitor of Metalloproteinase-3IBA
01/2022
1KJ-Pyr-9IBA
10/2021
1Insulin-Like PeptidesIBA
05/2021
1Insulin (Novolin)FDA Link
05/2021
1Metformin (Glucophage)FDA LinkGeneric
05/2021
1Aurora Kinase AIBA
01/2021
1CateninsIBA
12/2020
1morusinIBA
10/2020
1ThioredoxinsIBA
01/2020
1growth arrest specific transcript 5IBA
01/2020
1Phospholipid Hydroperoxide Glutathione PeroxidaseIBA
01/2020
1AntioxidantsIBA
01/2020
1Thioredoxin Reductase 1IBA
01/2020
1Arsenic Trioxide (Trisenox)FDA Link
12/2019

Therapy/Procedure

10Therapeutics
05/2021 - 06/2009
4Hysterectomy
05/2010 - 05/2002
3Radiotherapy
12/2021 - 01/2011
3Length of Stay
11/2013 - 10/2011
2Drug Therapy (Chemotherapy)
12/2021 - 01/2011